SCHEMBL20156287

SCHEMBL20156287

Cc1ccc2c3ccc(C)cc3n(-c3ccc(-c4nc(C)nc(C)n4)c(C#N)c3)c2c1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM2 Q14416 1/20 0.34
ALDH1A1 P00352 7/20 0.34
HPGD P15428 5/20 0.34
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
KDM4E B2RXH2 6/20 0.33
GAA P10253 3/20 0.33
GLA P06280 2/20 0.33
CASP1 P29466 2/20 0.33
CASP7 P55210 2/20 0.33
HSD17B10 Q99714 2/20 0.33
USP14 P54578 1/20 0.33
ESR1 P03372 1/20 0.33
ESR2 Q92731 1/20 0.33
RECQL P46063 1/20 0.33
CYP19A1 P11511 1/20 0.32
S1PR4 O95977 1/20 0.32
S1PR1 P21453 1/20 0.32
NT5E P21589 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20114645 0.94 GRM2 (0.38) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20156286 0.90 ALDH1A1 (0.34) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20156139 0.90 ALDH1A1 (0.34) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20156141 0.89 TDP2 (0.36) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL20114657 0.88 ALDH1A1 (0.38) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20114697 0.88 ALDH1A1 (0.38) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20150438 0.88 ALDH1A1 (0.39) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL20114714 0.87 ALDH1A1 (0.36) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL21116193 0.87 USP14 (0.37) GRM2ALDH1A1HPGDLMNAMAPK1
SCHEMBL20156213 0.86 ALDH1A1 (0.38) GRM2ALDH1A1HPGDLMNAMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 GRM2 1828/4885ALDH1A1 387/4885HPGD 2446/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 GRM2 1828/4885ALDH1A1 387/4885HPGD 2446/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.